<DOC>
	<DOCNO>NCT01037153</DOCNO>
	<brief_summary>Background : - Nicotine addiction common among people smoke tobacco , addictive property nicotine make smoke cessation difficult even people want quit . Research show smoking cause change brain lead addiction craving , research need determine different dos nicotine different interval receive nicotine affect brain function . A great understanding nicotine 's effect brain , study functional magnetic resonance imaging ( fMRI ) , may improve effectiveness smoke cessation therapy treatment . Objectives : - To determine effect nicotine brain function chemistry experience cigarette smoker . Eligibility : - Current smoker ( least 20 cigarette per day least 1 year ) 18 50 year age . Design : - The study involve five separate research experiment . Most participant involve one experiment . - The experiment evaluate brain activity function use fMRI . Participants trained series test cognitive function begin experimental part study . - Experiment 1 : Participants three fMRI scan session receive different dose level intravenous nicotine . - Experiment 2 : Participants four fMRI scan session receive two dos nicotine separated 1/4 , 1/2 , 3 , 24 hour . - Experiment 3 : Participants two set nicotine injection separate 45 minute , injection series contain five rapid injection small amount nicotine ( mimic five puff cigarette ) . - Experiment 4 : Participants three fMRI session receive single injection nicotine three different rate ( 15 , 60 , 120 second ) . In addition three session involve nicotine patch nicotine injection well placebo session . - Experiment 5 : Participants three fMRI session involve look different kind picture relate related smoking receive single injection nicotine . - Participants also provide blood sample study ... .</brief_summary>
	<brief_title>Effects Nicotine Brain Activity Measured fMRI</brief_title>
	<detailed_description>Objective : The overall goal protocol employ fMRI define nicotine 's neural pharmacokinetic pharmacodynamic property neurochemical site mechanisms action experience smoker correlate monoamine nicotinic receptor genotype well determine behavioral correlate nicotine various condition delivery regress behavioral correlate nicotine administration neuroanatomical site activation across subject . Study Population : The study population consist adult ( 18-50 y.o . ) non-treatment seek smoker . Subjects must smoke least 20 cigarette per day least 1 year . They dependent drug alcohol except nicotine caffeine . In addition , must appropriate candidate fMRI scan . Design : The study divide 5 separate arm maximum two arm conduct one time . The experimental arm explore effect intravenous nicotine delivery respect follow parameter : dosage , interval delivery , rate delivery emotional processing . Specifically arms follow : Experiment 1 : 3 fMRI scan session administer either 0.25 , 0.75 1.5 mg IV nicotine ; Experiment 2 : 4 fMRI scan session administer two dos 1.25 mg nicotine separate 0.25 , 0.75 , 3 24 hour ; Experiment 3 : two injection series separate 45 minute , injection series contain 5 rapid injection 0.25 mg , much like 5 puff cigarette ; Experiment 4 : 3 fMRI session administer single injection 1.5 mg nicotine 3 different rates- 15 , 60 120 second ; Experiment 5 : 3 fMRI session administer 1.5 mg nicotine follow exposure either neutral , negative , positive affect picture . Since experimental arm conduct series , rather parallel , subject common one experimental arm . Outcome Measures : The relevant outcome measure study behavioral physiological effect pattern brain region activate ( suppress ) follow intravenous administration nicotine across vary dos , interval , rate effect parameters emotional processing context nicotine stimuli different affective valence .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Subjects must age 18 50 good health , base history physical exam , must demonstrate experienced nicotine user base upon urine nicotine/cotinine level exhale CO. 2 . Subjects must smoke minimum 20 cigarettes/day least 1 year . 3 . Subjects may users alcohol and/or marijuana may meet criterion dependence either must negative urine drug triage prior scan . EXCLUSION CRITERIA : Subjects exclude : 1. unable undergo MRI scan due pregnancy , implant metallic device ( cardiac pacemaker neurostimulator , artificial joint , metal pin , surgical clip implant metal part ) claustrophobia . 2. major medical illness include , limited , hypertension , cardiovascular disease , asthma , diabetes , peripheral vascular disease , coagulopathies , history superficial deep vein thrombosis , HIV , infectious disease may affect CNS ( e.g . syphilis ) . 3. current major psychiatric disorder include , limited , mood , anxiety , psychotic disorder , substanceinduced psychiatric disorder . 4. history neurological illness seizure disorder , migraine , multiple sclerosis , movement disorder , history head trauma , CVA , CNS tumor . 5. alcohol drug dependence , nicotine dependence , 6. T1 weight brain MRI reveal gross structural abnormality , 7. history syncope . 8. pregnant 9. actively seek engage smoke cessation treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 25, 2011</verification_date>
	<keyword>Intravenous</keyword>
	<keyword>Rate Delivery</keyword>
	<keyword>Dose Responses</keyword>
	<keyword>Variable Intervals</keyword>
	<keyword>Multiple Rapid Injections</keyword>
</DOC>